Core Viewpoint - Rosen Law Firm is reminding investors who purchased Trip.com Group Limited securities between April 30, 2024, and January 13, 2026, of the May 11, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Trip.com securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is May 11, 2026, with the lead plaintiff representing other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false and misleading statements regarding Trip.com's regulatory risks and business operations, which led to investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Atara Biotherapeutics, Inc. securities, alleging misleading statements and undisclosed manufacturing issues that affected the company's regulatory prospects and financial condition during the Class Period from May 20, 2024, to January 9, 2026 [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Atara Biotherapeutics made false and misleading statements regarding manufacturing issues and the likelihood of FDA approval for its tabelecleucel Biologics License Application [5]. - The lawsuit alleges that these issues led to a heightened risk of regulatory scrutiny and jeopardized ongoing clinical trials, which negatively impacted Atara's business and financial condition [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, including a notable settlement against a Chinese company and ranking highly in securities class action services [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd. for the period between February 26, 2025, and February 24, 2026, due to alleged misleading statements and undisclosed information affecting the company's financial prospects [1][5]. Group 1: Lawsuit Details - The lawsuit claims that ODDITY's largest advertising partner made an algorithm change that diverted advertisements to lower quality auctions at abnormally high costs, significantly increasing customer acquisition costs [5]. - Defendants allegedly overstated the strength and sustainability of ODDITY's digital operating model and market position, leading to materially false and misleading public statements [5]. - Investors reportedly suffered damages when the true details about the company's operational challenges became public [5]. Group 2: Participation Information - Investors who purchased ODDITY securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by May 11, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at the firm have received recognition from Lawdragon and Super Lawyers, highlighting their expertise in this area [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Immutep Ltd due to allegations of materially misleading business information issued by the company [1] Group 1: Company Actions and Developments - On March 13, 2026, Immutep announced the discontinuation of the TACTI-004 Phase III study for eftilagimod alfa in non-small cell lung cancer, following a recommendation from the Independent Data Monitoring Committee based on a planned interim futility analysis [3] - The trial was halted due to the IDMC's conclusion that the available safety and efficacy data did not support its continuation, leading to an orderly wind down of the study [3] - Following this announcement, Immutep's American Depositary Receipt price fell by $2.28, or 82.6%, closing at $0.48 per ADR on March 13, 2026 [3] Group 2: Legal and Investor Implications - Investors who purchased Immutep securities may be entitled to compensation through a class action lawsuit being prepared by Rosen Law Firm, which operates on a contingency fee basis [2] - The firm encourages investors to select qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nektar Therapeutics securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Nektar securities between February 26, 2025, and December 15, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 5, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements since 2013 [4]. Group 3: Case Allegations - The lawsuit alleges that Nektar Therapeutics made false or misleading statements regarding the REZOLVE-AA trial, including improper enrollment and overstated trial integrity, which negatively impacted investors when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Lakeland Industries, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Lakeland securities between December 1, 2023, and December 9, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 24, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4]. Group 3: Case Allegations - The lawsuit alleges that Lakeland Industries made false and misleading statements regarding its Pacific Helmets and Jolly businesses, including issues with shipping, production, and product rollout [5]. - It is claimed that the defendants overstated the financial impact of these businesses and the effectiveness of their tariff mitigation measures, leading to unreliable financial guidance [5]. - The lawsuit asserts that when the true details became known, investors suffered damages due to the misleading public statements made by the defendants [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Paysafe Limited securities between March 4, 2025, and November 12, 2025, of the April 7, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Paysafe securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by April 7, 2026, to serve as lead plaintiff [2] - The lawsuit claims that Paysafe made false or misleading statements regarding its business operations and financial guidance, which led to investor damages when the truth was revealed [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Eos Energy Enterprises, Inc. securities between November 5, 2025, and February 26, 2026, of the May 5, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Eos Energy securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by May 5, 2026, to serve as lead plaintiff, representing other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone, and has consistently ranked in the top 4 for securities class action settlements since 2013 [4]. Group 3: Case Allegations - The lawsuit alleges that Eos Energy made false or misleading statements and failed to disclose critical operational issues, including an inability to meet production and capacity utilization targets, excessive battery line downtime, and delays in achieving quality targets for automated production [5]. - It is claimed that these issues led to materially misleading positive statements about Eos Energy's business and operations, resulting in investor damages when the true situation became known [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of TruBridge, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased TruBridge securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to TruBridge [2]. Group 2: Financial Reporting Issues - On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file its Annual Report for the fiscal year ended December 31, 2025, due to the identification of out-of-period errors in previously issued financial statements [3]. - The errors identified relate to revenue recognition, contract costs, stock-based compensation expenses, and capitalized software development expenses, necessitating revisions to financial statements for the years ended December 31, 2024, and December 31, 2023 [3]. - Following this announcement, TruBridge's stock price fell by $1.84 per share, or 10.5%, closing at $15.75 per share on March 17, 2026 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its success in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering investor losses [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PayPal Holdings, Inc. common stock between February 25, 2025, and February 2, 2026, of the April 20, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought PayPal common stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is April 20, 2026, with the lead plaintiff representing other class members in the litigation [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that PayPal's management provided misleading information regarding the company's financial targets for 2027 and the growth potential of its Branded Checkout segment [5]. - It is claimed that while management expressed confidence in PayPal's growth, they concealed material adverse facts about the salesforce's capability to meet these expectations, leading to investor damages when the truth was revealed [5].